Expression of aminopeptidase N and dipeptidyl peptidase IV in the healthy and asthmatic bronchus
- 1 January 1998
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 28 (1) , 110-120
- https://doi.org/10.1046/j.1365-2222.1998.00198.x
Abstract
Asthma is characterized by reversible airway obstruction, airway hyperresponsiveness, and chronic inflammation of the airways. Since peptides are able to produce many of the pathophysiological features which are characteristic of asthma, peptide-mediated inflammation is thought to play a role in this disease. The effects of peptides are modulated by peptidases, which are able to degrade peptides, mostly resulting in their inactivation. In this study, we investigated the distribution of two peptidases, aminopeptidase N and dipeptidyl peptidase IV, in the human bronchus and determined whether their expression was altered in allergic asthmatics. We first determined the distribution of aminopeptidase N and dipeptidyl peptidase IV in the human bronchus using immuno- and enzymehistochemistry and compared this with the distribution of neutral endopeptidase. Secondly, the expression of aminopeptidase N and dipeptidyl peptidase IV was determined in bronchial biopsies of healthy subjects (n = 8) and allergic asthmatics (n = 12). Aminopeptidase N was localized in connective tissue, blood vessels, gland ducts, perichondrium, nerves and leucocytes (mainly mononuclear phagocytes, dendritic cells, and eosinophils). Dipeptidyl peptidase IV was localized in serosal glands, blood vessels, and T cells. Immunohistochemistry and enzymehistochemistry gave similar results. Comparison of the expression of aminopeptidase N and dipeptidyl peptidase IV in bronchial biopsies of healthy controls and atopic asthmatics revealed no significant differences in the lamina propria. In contrast, in the bronchial epithelium of atopic asthmatics an increased number of aminopeptidase N-positive cells could be found. Double-staining identified these cells as L25+ dendritic cells and eosinophils. We conclude that expression of aminopeptidase N and dipeptidyl peptidase IV is restricted to specific sites within the human bronchus. Furthermore, in the bronchial epithelium of allergic asthmatics an increased number of aminopeptidase N-expressing dendritic cells and eosinophils can be found.Keywords
This publication has 38 references indexed in Scilit:
- Differential effects of phosphoramidon and captopril on NK1 receptor-mediated plasma extravasation in the rat tracheaInflammation Research, 1994
- CD26: a surface protease involved in T-cell activationImmunology Today, 1994
- Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N‐terminal cytokine sequencesFEBS Letters, 1993
- Vasoactive Intestinal Polypeptide (VIP) in AsthmaaAnnals of the New York Academy of Sciences, 1991
- Peptidase Modulation of the Pulmonary Effects of TachykininsInternational Archives of Allergy and Immunology, 1991
- Recombinant human enkephalinase (neutral endopeptidase) prevents cough induced by tachykinins in awake guinea pigs.Journal of Clinical Investigation, 1989
- Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N.Journal of Clinical Investigation, 1989
- Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase.The Journal of Experimental Medicine, 1988
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984
- A New Immunologic Marker for Human Langerhans CellsNew England Journal of Medicine, 1981